{"raw_mentions": "In a preferred embodiment, the equilibrium dissociation constant (KD) between the viral FcR or immunogenic fragment thereof and human IgGs is higher than 2 x 10^7 M, preferably higher than 5 x 10^7 M, more preferably higher than 1 x 10^6 M.\nIn a preferred embodiment, the response in a BiLayer Interferometry assay corresponding to the binding between the viral Fc receptor or immunogenic fragment thereof and human IgGs is lower than 0.4 nm, suitably lower than 0.3 nm, 0.2 nm or 0.1 nm."}
{"final_json": [{"molecule_name": "viral FcR or immunogenic fragment thereof", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "> 2 x 10^7", "unit": "M"}, {"molecule_name": "viral FcR or immunogenic fragment thereof", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "> 5 x 10^7", "unit": "M"}, {"molecule_name": "viral FcR or immunogenic fragment thereof", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "> 1 x 10^6", "unit": "M"}, {"molecule_name": "viral Fc receptor or immunogenic fragment thereof", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "response in BiLayer Interferometry assay", "value": "< 0.4", "unit": "nm"}, {"molecule_name": "viral Fc receptor or immunogenic fragment thereof", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "response in BiLayer Interferometry assay", "value": "< 0.3", "unit": "nm"}, {"molecule_name": "viral Fc receptor or immunogenic fragment thereof", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "response in BiLayer Interferometry assay", "value": "< 0.2", "unit": "nm"}, {"molecule_name": "viral Fc receptor or immunogenic fragment thereof", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "response in BiLayer Interferometry assay", "value": "< 0.1", "unit": "nm"}]}
{"raw_mentions": "In a preferred embodiment, the equilibrium dissociation constant (KD) between the viral FcR ectodomain and human IgGs is higher than 2 x 10^7 M, preferably higher than 5 x 10^7 M, more preferably higher than 1 x 10^6 M.\nIn a preferred embodiment, the response in a BiLayer Interferometry assay corresponding to the binding between the viral FcR ectodomain and human IgGs is lower than 0.6 nm, suitably lower than 0.5 nm, 0.4 nm, 0.3 nm or 0.2 nm."}
{"final_json": [{"molecule_name": "viral FcR ectodomain", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": ">2 x 10^7", "unit": "M"}, {"molecule_name": "viral FcR ectodomain", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": ">5 x 10^7", "unit": "M"}, {"molecule_name": "viral FcR ectodomain", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": ">1 x 10^6", "unit": "M"}, {"molecule_name": "viral FcR ectodomain", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "response in BiLayer Interferometry assay", "value": "<0.6", "unit": "nm"}, {"molecule_name": "viral FcR ectodomain", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "response in BiLayer Interferometry assay", "value": "<0.5", "unit": "nm"}, {"molecule_name": "viral FcR ectodomain", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "response in BiLayer Interferometry assay", "value": "<0.4", "unit": "nm"}, {"molecule_name": "viral FcR ectodomain", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "response in BiLayer Interferometry assay", "value": "<0.3", "unit": "nm"}, {"molecule_name": "viral FcR ectodomain", "protein_target_name": "human IgGs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "response in BiLayer Interferometry assay", "value": "<0.2", "unit": "nm"}]}
{"raw_mentions": "There are no sentences or table rows in the provided text that contain all of the required elements: a bioactivity metric (IC50, Ki, Kd, EC50), a specific numeric value associated with that metric, and a unit for that value."}
{"raw_mentions": "None"}
{"raw_mentions": "Here are the extracted sentences with concrete data points that meet the specified criteria:\n\n\nPotency was determined as the dose of SAM LNP needed to transfect 50% of cultured cells (EC50) in a well of a 96-well plate.\nAll HSV SAM LNP candidates provided potent EC50 responses (Table 23)."}
{"final_json": [{"molecule_name": "SAM LNP", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": "HSV SAM LNP candidates", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": null, "unit": null}]}
